UK Drugs Policy

Keith Vaz Excerpts

Thursday 30th October 2014 Commons Chamber

[Caroline Lucas]

I thank the hon. Gentleman for his intervention and absolutely agree with him. Reviews take place in many other policy areas to check whether objectives are being met, and it is high time we had such a review of the 1971 Act.

The Government’s drugs strategy is itself subject to review, but that is a self-limiting process. In other words, it intends to look only at value for money and in terms only of whether the amount spent is more or less than the value of the positive outcomes. That review will be carried out in 2015 and it will not consider whether other approaches would be better value for money. Neither will it include the negative outcomes—the presumably unintended consequences—of the policy in its calculations.

I warmly welcome today’s publication of the Government’s international comparators study. I pay tribute to the Minister for Crime Prevention, who is in his place, for the leadership he has shown in the process. The study has been long awaited. It was commissioned on the recommendation of the Home Affairs Committee and is a considered review of the different approaches to drug policy pursued around the world.

The review indicates that introducing an alternative to prohibition would not, contrary to some claims, boost drug use, and it could save millions of pounds if users were treated for addiction rather than jailed. It seems that the evidence for the issue of drug use to be moved to the Department of Health, in order for the focus to be on treating rather than punishing addiction, is overwhelming as well. This is just the first step towards a drugs policy that puts harm reduction first, and I welcome it warmly, but we urgently need to follow up on this comparison of international approaches and learn the lessons from it for our own UK-based legislation. That is why this debate is so important.

[Keith Vaz (Leicester East) (Lab)]

May I also congratulate the hon. Lady, not only on her award, which is well deserved, but on her work on this issue? In respect of following up, I also welcome the report led by the Minister. The Home Affairs Committee, prompted by the hon. Member for Cambridge (Dr Huppert), will hold a separate session specifically on our last set of recommendations. It will be held in Cambridge, in honour of the hon. Gentleman, and I hope we can persuade the hon. Lady to come along and speak.

[Caroline Lucas]

I pay tribute to the right hon. Gentleman for all his leadership on this issue as Chair of the Home Affairs Committee, and to the hon. Member for Cambridge (Dr Huppert). I am very happy to take up that kind invitation. To be serious, I am very glad that the Home Affairs Committee is doing that extra piece of very important work.

Such work is important because drug misuse destroys individuals, families and communities, and an ineffective drugs policy only compounds that damage. All too often, success in the war on drugs is measured in numbers of arrests or seizures of drugs, but many of us believe that we should assess whether the harms associated with drug misuse are rising or declining.

The Home Secretary acknowledged in the foreword to her Government’s drug strategy:

“Individuals do not take drugs in isolation from what is happening in the rest of their lives.”

I agree. Poverty, social exclusion and inequality all have an impact on drug use and drug markets. Research by the Equality Trust has shown a clear and demonstrable correlation between drug misuse and inequality. There is a strong tendency for drug abuse to be more common in countries, such as the UK, that are more unequal. Ending social exclusion must therefore be at the heart of any effective strategy to reduce drug-related harms. To do that, we need to marshal the evidence.

--- Later in debate ---

[Keith Vaz (Leicester East) (Lab)]

I was not planning to speak in this debate, because I felt that most of what I have to say would be covered by the hon. Members for Brighton, Pavilion (Caroline Lucas) and for Cambridge (Dr Huppert), and my hon. Friend the Member for Newport West (Paul Flynn). However, I want to emphasise a couple of important points, which I hope will help the House to understand the issue.

The Home Affairs Committee has looked carefully at this issue and took a year producing a report, including a visit to Portugal. I was not able to go, but other colleagues, including the hon. Members for Hertsmere (Mr Clappison) and for Cambridge, as well as the then hon. Member for Rochester and Strood, went to Portugal and provided a good outline of what is happening there. The hon. Member for Totnes (Dr Wollaston), Chair of the Health Committee, is right: we need to make comparisons and see what works elsewhere. That was reflected in the excellent speech by the hon. Member for Brighton, Pavilion, who has campaigned long and hard on this issue.

The main conclusion of the Committee’s report in 2012 was to urge the Government to initiate a royal commission, which we said could be done in a short period of time. We were not in favour of a royal commission that would last an age, and we felt that it could be completed to a timetable. Had that been accepted in 2012, we would have had the results by now; sadly, the idea was not taken up by the Government. I do not think a royal commission will be set up in the next six months, but I hope that future Governments will see it as a way of ensuring that all voices on drugs policy are heard. There are many voices out there, as we see from the number of right hon. and hon. Members who wish to take part in the debate, many of whom have great expertise in this matter. Let us hear all those voices, take the evidence, and come to a conclusion. A Select Committee can only do so much—all Select Committees try their best to cover a full agenda—and a royal commission would enable us to do much more.

[Mr Mike Hancock]

Will the right hon. Gentleman draw the attention of his Committee very rapidly to the issue raised by the hon. Member for Richmond Park (Zac Goldsmith)—I also raised it in the Chamber 30 years ago—about people going into prison and coming out as heroin addicts? There needs to be a review of the way that prisons combat drugs, and I hope the Home Affairs Committee will take up the issue rapidly.

[Keith Vaz]

The first point I was going to make about drugs policy after calling for a royal commission was about prisons. The issue was raised by the hon. Member for Richmond Park (Zac Goldsmith), and brilliantly and eloquently exposed in the book by the hon. Member for Hexham (Guy Opperman), who is sitting behind the Minister. He has great knowledge and expertise from his years at the criminal Bar, and he mentioned many different aspects of the criminal justice system. There is a whole chapter on drugs in prison, and I commend the book to Members of the House. He may even have copies of it to sell to Members after the debate.

The Committee called for mandatory testing of prisoners on entry and exit, and we wanted to ensure that on exit, ex-prisoners are met at the gates and given the treatment they deserve, so that they do not reoffend and go back to prison. We found, as the hon. Member for Richmond Park said, that a quarter of prisoners first discover a taste for drugs while in prison. That is a shocking statistic and the number may even have gone up. Drugs are being used in prison and it is not acceptable. The prison authorities need to do much more, but we need to rehabilitate people, so that they do not reoffend as soon as they come out. A former Minister with responsibility for prisons is in the Chamber. He will have more knowledge of that, but I hope we get commitments from the Government and the Minister that more will be done.

[Ian Swales]

Will the right hon. Gentleman ensure that, in any work his Committee does on drugs in prison, we do not narrowly define drugs? Legal and illegal drugs have been mentioned in the debate. I know from a visit to my local prison that the main drug misuse is of prescription drugs.

[Keith Vaz]

That was going to be my second point. I have a feeling that Liberal Democrat Members have a copy of my speech.

[Mr Deputy Speaker (Mr Lindsay Hoyle)]

That is impossible. You were not going to speak.

[Keith Vaz]

Exactly. The Liberal Democrats have an incredible mind. They are able to predict exactly what hon. Members are going to say.

Correctly, the hon. Gentleman referred to prescription drugs, which had not been mentioned. The Committee was extremely concerned by the increase in the use of prescription drugs. Indeed, when the Committee was in Miami, as hon. Members would expect it to be, en route for Colombia to look at where 70% of the cocaine in our country comes from—we have done our homework—we heard of the first case of an American doctor being prosecuted for prescribing drugs. As we know, drugs become currency in prisons and outside. That is why there is a responsibility on the medical profession to ensure that doctors prescribe effectively and understand what is happening to prescription drugs if certain patients keep coming in and asking for them. It is important to ensure that we consider the availability of those drugs, which are perfectly legal.

I have not seen the Government statement on psychoactive substances so I cannot comment on it—I believe it was a written statement, and they never send the Committee advance copies. I just remind the House that the Committee was clear that the onus ought to be on the retailers who sell psychoactive substances. I did not realise that the Government were calling for a complete ban, but where psychoactive substances are sold, we should prosecute retailers for selling them. There is no point waiting for someone to die. It is essential we do something at the beginning by getting those who sell the drugs in the first place.

My final point is on money laundering and the weakness of successive Governments’ regimes to deal with criminality. As we have heard, the drugs trade is the second most profitable illegal activity in the world. It is worth some $380 billion a year, most of which enters the financial system, some through offshore areas such as Gibraltar and other areas of that kind. We need to ensure that authorities co-operate. I am not singling Gibraltar out because you are in the Chair, Mr Deputy Speaker.

[Mr Deputy Speaker]

Order. Just for correctness, I am not the chair of the Gibraltar group, but I was in the past. I am sure the right hon. Gentleman needs to take this up with the new chair.

[Keith Vaz]

There is no criticism of you, Mr Deputy Speaker, of the new chair of the all-party parliamentary group on Gibraltar or of anyone in Gibraltar, but we have discovered that some areas of the world are being used to launder money from drugs. Our financial authorities are not strong enough to deal with the way in which money goes through the system. That is why the Committee believes that bankers at the very senior level should be held criminally responsible if they know or are aware of laundering, or if they did not take action to prevent it.

[Stephen Barclay (North East Cambridgeshire) (Con)]

The right hon. Gentleman is right to consider asset recovery to deal with money laundering and criminal actions. He will be aware that we have an opportunity to consider that under the Serious Crime Bill. Does he share my concern about the drafting of the asset recovery clauses? Will his Committee consider that before we debate the Bill? Does he agree that the Bill needs to take on board lessons from places such as Italy?

[Keith Vaz]

The hon. Gentleman is absolutely right. I am not sure that the Committee has time to consider that before Christmas, but I will do so with him. Let us sit down and see whether we can get an amendment together. I am happy to support him to make the Bill tougher, because it needs to be.

I commend the proposers of the motion.. This is a very important debate, and we do not debate UK drugs policy often enough. We need to ensure that we have more time to debate this serious and important subject.

[Several hon. Members]

rose—

--- Later in debate ---

[Diana Johnson]

I do not want to be considered complacent, but we need to get all the evidence on the table so that we can assess it. There is some merit in looking at what has happened regarding treatment in this country over the past 10 to 12 years. The European Monitoring Centre for Drugs and Drug Addiction says that this country is well ahead of comparators. In 2010 60% of opioid users were in treatment. That compares with 12% in the Netherlands and 25% in Sweden, so I am not sure that I agree with the motion that the status quo is failing. Drug-related deaths among the under-30s have halved in a decade, and it has been calculated that getting people into drug treatment has prevented 4.9 million crimes being committed, saving the economy £960 million. This is evidence that we should all consider.

[Keith Vaz]

My hon. Friend has always been very thoughtful and careful in the way in which she has dealt with this issue. I agree that we need to get all the evidence out and examine it. Will members of the Opposition Front-Bench team commit to establishing a royal commission to look at the issue in detail so that we can base our policy on the evidence?

[Diana Johnson]

I am grateful to the Chair of the Select Committee. What worries me about the idea that a royal commission will solve the problem for us is that there are issues that we need to tackle now—for example, legal highs. I am pleased, as I said at the outset, that we now have a plan from the Government for legislation in relation to legal highs. I am not discounting a royal commission, but we need to keep abreast of the issues that are developing now. We need to put in place ways of tackling legal highs and other issues.

It is important to remember that access to treatment is a key issue. In 2001 it took nine weeks to access treatment; in 2011 it took five days. We should be mindful that that was because of the investment in health services. Once people are in treatment, it is important to make sure that they complete it. In 2005-06, 35,000 people dropped out and only 11,000 completed treatment, whereas in 2011-12, 17,000 dropped out but 29,000 completed treatment. We should be aware of such evidence when we debate the drugs situation.